- BASF finalized the purchase of DOMO Chemicals' 49% share in Alsachimie on July 1, 2025.
- The transaction involves production of PA 6.6 precursors like KA-oil, adipic acid, and AH salt.
- Financial details of the transaction remain undisclosed.
- BASF recently expanded PA 6.6 polymerization capacity in Freiburg, Germany.
Transaction Overview
On July 1, 2025, BASF completed the acquisition of DOMO Chemicals' 49% stake in the Alsachimie joint venture, becoming the sole owner of the production facility in Chalampé, France. This facility is crucial for producing essential polyamide (PA) 6.6 precursors, including KA-oil, adipic acid, and hexamethylenediamine adipate (AH salt). The financial terms of the transaction have not been disclosed.
Strategic Implications for BASF
With full ownership of Alsachimie, BASF aims to strengthen its operational presence at the Chalampé site, which serves as its European hub for PA 6.6 production. This strategic move is intended to enhance BASF's ability to optimize backward integration into key raw materials, thereby ensuring supply reliability and efficiency across the PA 6.6 value chain.
DOMO Chemicals' Strategic Focus
For DOMO Chemicals, the sale aligns with its strategy to concentrate on delivering tailored polyamide solutions to core industries such as automotive, consumer goods, industrial, and electrical and electronics. This allows DOMO to focus on its core competencies and market segments.
Recent Developments at BASF
The acquisition is part of BASF's broader strategy to bolster its PA 6.6 production capabilities. Recent developments include the inauguration of a state-of-the-art hexamethylenediamine (HMD) plant and the expansion of PA 6.6 polymerization capacity at the nearby Freiburg site in Germany. These initiatives are designed to support BASF's long-term growth and operational efficiency in the polyamide sector.
